MB 1
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 108179

Direct-Acting Vasodilators Hydralazine Clinical use QID: 108179 (M1.CV.17.4698)
In scope icon M 3 C
QID 108179 (Type "108179" in App Search)
A 52-year-old male with ischemic cardiomyopathy presents to his cardiologist for worsening shortness of breath on exertion. He denies any recent episodes of chest pain and has been compliant with his medications, which include metoprolol, lisinopril, spironolactone, and furosemide. The patient’s vitals signs are as follows: Temperature is 98.7 deg F (37.1 deg C), blood pressure is 163/78 mmHg, pulse is 92/min, respirations are 14/min, and oxygen saturation is 98% on room air. A repeat echocardiogram reveals a stable LVEF of 25-35%. The physician decides to start hydralazine and isosorbide dinitrate. Which of the following is true regarding this medication combination?
Type in at least one full word to see suggestions list